chitosan has been researched along with Acute Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Fan, JJ; Hu, JH; Huang, CL; Huang, ZH; Lu, YY; Mei, QX; Wang, XP; Zeng, Y | 1 |
Evancho-Chapman, MM; George, RL; Huang, H; Leipzig, ND; Li, H; Patil, PS; Shriver, LP | 1 |
Allam, AF; Farag, HF; Fawzy Hussein Mogahed, NM; Hagras, NA; Osman, MM; Shalaby, TI; Shehab, AY; Tolba, MM | 1 |
Chen, XQ; Jiang, XY; Jiao, FP; Tao, LJ; Yu, JG; Yu, LY | 1 |
Baranov, IA; Erlykina, EI; Koryagin, AS; Mochalova, AE; Murach, EI; Smirnova, LA | 1 |
Dreifke, MB; Jayasuriya, AA; Jayasuriya, AC | 1 |
Chatsudthipong, V; Muanprasat, C; Pichyangkura, R; Soodvilai, S; Yousef, M | 1 |
He, C; Tang, C; Yin, C; Yin, L | 1 |
Hirnle, L; Hirnle, P; Kubis, AA; Małolepsza-Jarmołowska, K | 1 |
2 review(s) available for chitosan and Acute Disease
Article | Year |
---|---|
Hemodialysis membranes for acute and chronic renal insufficiency.
Topics: Acute Disease; Animals; Cellulose; Chitosan; Humans; Membranes, Artificial; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
Current wound healing procedures and potential care.
Topics: Acute Disease; Biological Dressings; Cell- and Tissue-Based Therapy; Cellular Microenvironment; Chitosan; Chronic Disease; Collagen; Humans; Hyaluronic Acid; Intercellular Signaling Peptides and Proteins; MicroRNAs; RNA, Small Interfering; Silicon; Wound Healing; Wounds and Injuries | 2015 |
7 other study(ies) available for chitosan and Acute Disease
Article | Year |
---|---|
Pretreatment with chitosan oligosaccharides attenuate experimental severe acute pancreatitis via inhibiting oxidative stress and modulating intestinal homeostasis.
Topics: Acute Disease; Animals; Apoptosis; Chitin; Chitosan; Gastrointestinal Microbiome; Homeostasis; Intestines; Male; Mice, Inbred C57BL; Oligosaccharides; Oxidative Stress; Pancreas; Pancreatitis; Signal Transduction | 2021 |
Fluorinated methacrylamide chitosan hydrogel dressings enhance healing in an acute porcine wound model.
Topics: Acrylamides; Acute Disease; Animals; Bandages; Chitosan; Disease Models, Animal; Fluorocarbon Polymers; Hydrogels; Swine; Wound Healing; Wounds and Injuries | 2018 |
Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
Topics: Acute Disease; Animals; Ascitic Fluid; Biocompatible Materials; Blood-Brain Barrier; Brain; Chitosan; Coccidiostats; Drug Combinations; Drug Delivery Systems; Kaplan-Meier Estimate; Liver; Male; Metronidazole; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Pilot Projects; Spiramycin; Spleen; Survival Rate; Tablets; Toxoplasma; Toxoplasmosis, Animal | 2019 |
Adaptogenic effects of dihydroquercetin-chitosan composition during modeling of acute hypoxia.
Topics: Acute Disease; Animals; Chitosan; Hypoxia; Male; Models, Biological; Quercetin; Rats | 2014 |
Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Topics: Acetic Acid; Acute Disease; Administration, Oral; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Chitosan; Chronic Disease; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Gastrointestinal Agents; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-6; Intestinal Mucosa; Male; Mice; Mice, Inbred ICR; NF-kappa B; Oxidative Stress; Permeability; Reactive Oxygen Species; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha | 2012 |
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
Topics: Acute Disease; Administration, Oral; Animals; Caco-2 Cells; Chitosan; Cysteine; Gene Silencing; Humans; Inflammation; Liver; Liver Diseases; Macrophages; Male; Mice; Mice, Inbred C57BL; Nanoconjugates; Nanoparticles; Polymers; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2013 |
[Acute, hemorrhagic, overgrowing vaginal inflammation caused by Streptococcus agalacitae--case study].
Topics: Acute Disease; Administration, Intravaginal; Anti-Bacterial Agents; Chitosan; Female; Humans; Inflammation; Lactic Acid; Middle Aged; Streptococcal Infections; Streptococcus agalactiae; Treatment Outcome; Vaginal Discharge; Vaginosis, Bacterial | 2006 |